GNPTAB

UniProt ID: Q3T906
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

GNPTAB encodes the alpha/beta-subunit precursor of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (EC 2.7.8.17), the alpha2beta2gamma2 Golgi membrane enzyme complex (with GNPTG) that transfers GlcNAc-1-phosphate from UDP-GlcNAc to mannose residues of high-mannose N-glycans on soluble lysosomal acid hydrolases. This is the first step in generating the mannose 6-phosphate (M6P) recognition marker that directs hydrolases to M6P receptors and thence to endosomes and lysosomes. The alpha/beta subunits are catalytic and also recognise a conformational protein determinant on acid hydrolases; the precursor is activated in the Golgi by site-1 protease cleavage and depends on LYSET/TMEM251 for stability and Golgi retention. Biallelic loss of GNPTAB causes mucolipidosis II (I-cell disease) and, with residual activity, mucolipidosis III alpha/beta.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000139 Golgi membrane
EXP
PMID:16120602
The alpha- and beta-subunits of the human UDP-N-acetylglucos...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
EXP
PMID:16200072
Mucolipidosis II is caused by mutations in GNPTA encoding th...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
EXP
PMID:21719679
A key enzyme in the biogenesis of lysosomes is a protease th...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
EXP
PMID:25788519
Analyses of disease-related GNPTAB mutations define a novel ...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
EXP
PMID:28918368
GNPTAB missense mutations cause loss of GlcNAc-1-phosphotran...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
IDA
PMID:23733939
The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
IDA
PMID:24375680
Mucolipidosis II-related mutations inhibit the exit from the...
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0000139 Golgi membrane
IEA
GO_REF:0000120
ACCEPT
Summary: GNPTAB alpha and beta subunits are Golgi membrane proteins.
Reason: Multiple experimental studies localise the alpha/beta precursor and its cleaved subunits to the Golgi, where it is activated and acts on newly synthesised hydrolases.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IDA
PMID:19955174
Functions of the alpha, beta, and gamma subunits of UDP-GlcN...
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IDA
PMID:23733939
The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N...
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IDA
PMID:25788519
Analyses of disease-related GNPTAB mutations define a novel ...
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
IMP
PMID:25505245
Analysis of mucolipidosis II/III GNPTAB missense mutations i...
ACCEPT
Summary: GlcNAc-1-phosphotransferase activity is the core catalytic function of GNPTAB.
Reason: Recombinant alpha/beta subunits carry the catalytic activity (EC 2.7.8.17); disease mutations in catalytic and recognition domains abolish phosphorylation of acid hydrolases.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:16120602
results in a 3.6- or 17-fold increase in GlcNAc-phosphotransferase activity in cell lysates, suggesting that the precursor cDNA contains the catalytic domain
PMID:25505245
We show that the Stealth domain harbors the catalytic site
GO:0005509 calcium ion binding
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Calcium ion binding is inferred from an EF-hand-like InterPro signature only.
Reason: The signature support is stronger than an EF-hand domain call alone - UniProt annotates per-residue Ca(2+) BINDING features, in the EF-hand domain at 1005..1040 and in the LNR repeats - but every one is ECO:0000255, inferred from a sequence model rather than measured, so calcium binding by GNPTAB and its functional relevance still have not been demonstrated experimentally. Non-core on the strength of the evidence, not on doubt about the signature.
Supporting Evidence:
file:human/GNPTAB/GNPTAB-uniprot.txt
/note="EF-hand"
file:human/GNPTAB/GNPTAB-uniprot.txt
/ligand="Ca(2+)"
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: High-throughput interactome hit without functional support.
Reason: Binary Y2H/AP-MS interaction from a proteome-scale screen; the partner has no known role in M6P tagging and several are nuclear or cytosolic, inconsistent with the luminal/Golgi topology of GNPTAB. 'protein binding' is in any case uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: High-throughput interactome hit without functional support.
Reason: Binary Y2H/AP-MS interaction from a proteome-scale screen; the partner has no known role in M6P tagging and several are nuclear or cytosolic, inconsistent with the luminal/Golgi topology of GNPTAB. 'protein binding' is in any case uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: High-throughput interactome hit without functional support.
Reason: Binary Y2H/AP-MS interaction from a proteome-scale screen; the partner has no known role in M6P tagging and several are nuclear or cytosolic, inconsistent with the luminal/Golgi topology of GNPTAB. 'protein binding' is in any case uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: High-throughput interactome hit without functional support.
Reason: Binary Y2H/AP-MS interaction from a proteome-scale screen; the partner has no known role in M6P tagging and several are nuclear or cytosolic, inconsistent with the luminal/Golgi topology of GNPTAB. 'protein binding' is in any case uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
REMOVE
Summary: High-throughput interactome hit without functional support.
Reason: Binary Y2H/AP-MS interaction from a proteome-scale screen; the partner has no known role in M6P tagging and several are nuclear or cytosolic, inconsistent with the luminal/Golgi topology of GNPTAB. 'protein binding' is in any case uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network
GO:0005515 protein binding
IPI
PMID:26385638
Subunit interactions of the disease-related hexameric GlcNAc...
MODIFY
Summary: GNPTAB binds the gamma subunit GNPTG as part of the hexameric GlcNAc-1-phosphotransferase.
Reason: The interaction is real and functionally important, but is better captured as membership of the GlcNAc-1-phosphotransferase complex than as generic protein binding.
Supporting Evidence:
PMID:26385638
we identified the binding regions of Ξ³-subunits in a previously uncharacterized domain of Ξ±-subunits comprising residues 535-698, named GNPTG binding (GB) domain
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
REMOVE
Summary: AP-MS co-purification with the Golgi glycosyltransferase B3GALT2 in BioPlex, without functional follow-up.
Reason: Co-residence in the Golgi plausibly explains co-purification; there is no evidence of a functional interaction, and 'protein binding' is uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:28514442
Architecture of the human interactome defines protein communities and disease networks
GO:0005515 protein binding
IPI
PMID:28514442
Architecture of the human interactome defines protein commun...
MODIFY
Summary: GNPTAB binds the gamma subunit GNPTG as part of the hexameric GlcNAc-1-phosphotransferase.
Reason: The interaction is real and functionally important, but is better captured as membership of the GlcNAc-1-phosphotransferase complex than as generic protein binding.
Supporting Evidence:
PMID:26385638
we identified the binding regions of Ξ³-subunits in a previously uncharacterized domain of Ξ±-subunits comprising residues 535-698, named GNPTG binding (GB) domain
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
REMOVE
Summary: AP-MS co-purification with the Golgi glycosyltransferase B3GALT2 in BioPlex, without functional follow-up.
Reason: Co-residence in the Golgi plausibly explains co-purification; there is no evidence of a functional interaction, and 'protein binding' is uninformative. Removal does not assert the interaction is false.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
GO:0005515 protein binding
IPI
PMID:36074821
The human disease gene LYSET is essential for lysosomal enzy...
REMOVE
Summary: GNPTAB binds the Golgi membrane protein LYSET, which stabilises it and retains it in the Golgi.
Reason: A functionally validated interaction (LYSET loss destabilises and mislocalises GNPTAB), but the activity belongs to LYSET as a regulator; for GNPTAB the generic 'protein binding' term adds no functional information. The interaction itself is real and is captured on the LYSET review; removal does not assert it is false.
Supporting Evidence:
PMID:36074821
LYSET deficiency resulted in global loss of M6P tagging and mislocalization of GlcNAc-1-phosphotransferase from the Golgi complex to lysosomes.
GO:0005794 Golgi apparatus
IBA
GO_REF:0000033
ACCEPT
Summary: GNPTAB localises to the Golgi apparatus.
Reason: Consistent with its Golgi membrane localisation; Golgi membrane is the more specific term.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0005794 Golgi apparatus
IDA
GO_REF:0000052
ACCEPT
Summary: GNPTAB localises to the Golgi apparatus.
Reason: Consistent with its Golgi membrane localisation; Golgi membrane is the more specific term.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0005794 Golgi apparatus
IDA
PMID:21719679
A key enzyme in the biogenesis of lysosomes is a protease th...
ACCEPT
Summary: GNPTAB localises to the Golgi apparatus.
Reason: Consistent with its Golgi membrane localisation; Golgi membrane is the more specific term.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0005794 Golgi apparatus
IDA
PMID:25505245
Analysis of mucolipidosis II/III GNPTAB missense mutations i...
ACCEPT
Summary: GNPTAB localises to the Golgi apparatus.
Reason: Consistent with its Golgi membrane localisation; Golgi membrane is the more specific term.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0005794 Golgi apparatus
IDA
PMID:25788519
Analyses of disease-related GNPTAB mutations define a novel ...
ACCEPT
Summary: GNPTAB localises to the Golgi apparatus.
Reason: Consistent with its Golgi membrane localisation; Golgi membrane is the more specific term.
Supporting Evidence:
PMID:16200072
expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
PMID:25788519
Upon arrival in the Golgi apparatus, the newly synthesized Ξ±/Ξ²-subunit precursor is catalytically activated by site-1 protease (S1P).
GO:0006487 protein N-linked glycosylation
IBA
GO_REF:0000033
MODIFY
Summary: GNPTAB modifies existing N-glycans rather than performing N-linked glycosylation.
Reason: The more accurate process is the M6P-generating N-glycan processing step.
Proposed replacements: N-glycan processing to lysosome
Supporting Evidence:
PMID:19955174
mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
GO:0007040 lysosome organization
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Lysosome organization/biogenesis depends on M6P-mediated hydrolase delivery.
Reason: Loss of GNPTAB (or of its activating protease S1P) disrupts lysosome biogenesis, but this is a downstream consequence of the core N-glycan processing role.
Supporting Evidence:
PMID:21719679
S1P-deficient cells failed to activate the Ξ±/Ξ²-subunit precursor and exhibited a mucolipidosis II-like phenotype.
GO:0007040 lysosome organization
IMP
PMID:21719679
A key enzyme in the biogenesis of lysosomes is a protease th...
KEEP AS NON CORE
Summary: Lysosome organization/biogenesis depends on M6P-mediated hydrolase delivery.
Reason: Loss of GNPTAB (or of its activating protease S1P) disrupts lysosome biogenesis, but this is a downstream consequence of the core N-glycan processing role.
Supporting Evidence:
PMID:21719679
S1P-deficient cells failed to activate the Ξ±/Ξ²-subunit precursor and exhibited a mucolipidosis II-like phenotype.
GO:0015031 protein transport
IEA
GO_REF:0000117
MODIFY
Summary: Protein transport is too general; GNPTAB acts in the M6P tagging step of lysosomal enzyme targeting.
Reason: GNPTAB does not itself transport proteins; it generates the targeting signal.
Proposed replacements: N-glycan processing to lysosome
Supporting Evidence:
PMID:25505245
UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system.
GO:0016256 N-glycan processing to lysosome
IBA
GO_REF:0000033
ACCEPT
Summary: GNPTAB catalyses the first step of N-glycan processing that generates the M6P lysosomal targeting signal.
Reason: This process is exactly what GlcNAc-1-phosphotransferase does; GNPTAB-null cells hypersecrete hydrolases and wild-type cDNA corrects the defect.
Supporting Evidence:
PMID:19955174
mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
PMID:19938078
the biochemical phenotypes of MLII and MLIII fibroblasts can be corrected by transfection with wild-type cDNA expression constructs encoding the alpha/beta- and gamma-subunits of GlcNAc-1-phosphotransferase
PMID:25505245
UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system.
GO:0016256 N-glycan processing to lysosome
IMP
PMID:19938078
Molecular analysis of cell lines from patients with mucolipi...
ACCEPT
Summary: GNPTAB catalyses the first step of N-glycan processing that generates the M6P lysosomal targeting signal.
Reason: This process is exactly what GlcNAc-1-phosphotransferase does; GNPTAB-null cells hypersecrete hydrolases and wild-type cDNA corrects the defect.
Supporting Evidence:
PMID:19955174
mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
PMID:19938078
the biochemical phenotypes of MLII and MLIII fibroblasts can be corrected by transfection with wild-type cDNA expression constructs encoding the alpha/beta- and gamma-subunits of GlcNAc-1-phosphotransferase
PMID:25505245
UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system.
GO:0016256 N-glycan processing to lysosome
IMP
PMID:25505245
Analysis of mucolipidosis II/III GNPTAB missense mutations i...
ACCEPT
Summary: GNPTAB catalyses the first step of N-glycan processing that generates the M6P lysosomal targeting signal.
Reason: This process is exactly what GlcNAc-1-phosphotransferase does; GNPTAB-null cells hypersecrete hydrolases and wild-type cDNA corrects the defect.
Supporting Evidence:
PMID:19955174
mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
PMID:19938078
the biochemical phenotypes of MLII and MLIII fibroblasts can be corrected by transfection with wild-type cDNA expression constructs encoding the alpha/beta- and gamma-subunits of GlcNAc-1-phosphotransferase
PMID:25505245
UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase tags newly synthesized lysosomal enzymes with mannose 6-phosphate recognition markers, which are required for their targeting to the endolysosomal system.
GO:0016772 transferase activity, transferring phosphorus-containing groups
IEA
GO_REF:0000002
MODIFY
Summary: Generic phosphorus-group transferase activity; the specific activity is known.
Reason: Replace with the specific EC 2.7.8.17 GlcNAc-1-phosphotransferase activity term.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
GO:0046835 carbohydrate phosphorylation
IDA
PMID:19955174
Functions of the alpha, beta, and gamma subunits of UDP-GlcN...
KEEP AS NON CORE
Summary: GNPTAB transfers GlcNAc-1-phosphate to mannose residues, a form of carbohydrate phosphorylation.
Reason: Accurate but general; the specific process is N-glycan processing to lysosome.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:23733939
the DMAP interaction domain of the Ξ± subunit functions in the selective recognition of acid hydrolase substrates
GO:0046835 carbohydrate phosphorylation
IDA
PMID:23733939
The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N...
KEEP AS NON CORE
Summary: GNPTAB transfers GlcNAc-1-phosphate to mannose residues, a form of carbohydrate phosphorylation.
Reason: Accurate but general; the specific process is N-glycan processing to lysosome.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:23733939
the DMAP interaction domain of the Ξ± subunit functions in the selective recognition of acid hydrolase substrates
GO:0046835 carbohydrate phosphorylation
IEA
GO_REF:0000117
KEEP AS NON CORE
Summary: GNPTAB transfers GlcNAc-1-phosphate to mannose residues, a form of carbohydrate phosphorylation.
Reason: Accurate but general; the specific process is N-glycan processing to lysosome.
Supporting Evidence:
PMID:19955174
the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
PMID:23733939
the DMAP interaction domain of the Ξ± subunit functions in the selective recognition of acid hydrolase substrates

Core Functions

Catalytic alpha/beta subunits of the Golgi GlcNAc-1-phosphotransferase complex that recognise soluble lysosomal acid hydrolases and transfer GlcNAc-1-phosphate from UDP-GlcNAc to their high-mannose N-glycans, the first step in forming the mannose 6-phosphate lysosomal targeting signal.

Supporting Evidence:
  • PMID:19955174
    the alpha/beta subunits recognize the protein determinant of acid hydrolases in addition to mediating the catalytic function of the transferase
  • PMID:19955174
    mediates the first step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal acid hydrolases
  • PMID:16200072
    expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes
  • PMID:21719679
    Cleavage of the membrane-bound Ξ±/Ξ²-subunit precursor by an unknown protease is required for catalytic activity.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Is LYSET a stoichiometric subunit of the GlcNAc-1-phosphotransferase complex or a transient chaperone/retention factor?

Suggested experts: lysosomal enzyme trafficking biochemists

Suggested Experiments

Experiment: Cryo-EM of endogenous GlcNAc-1-phosphotransferase purified from human Golgi membranes, with and without LYSET.

Hypothesis: LYSET binds the hydrophilic transmembrane segment of the GNPTAB beta subunit and is part of the active Golgi complex.

Type: structural biology

Deep Research

Falcon

(GNPTAB-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(GNPTAB-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)